Annual Operating Expenses
$128.54 M
+$15.56 M+13.77%
31 December 2023
Summary:
Anika Therapeutics annual total operating expenses is currently $128.54 million, with the most recent change of +$15.56 million (+13.77%) on 31 December 2023. During the last 3 years, it has risen by +$45.04 million (+53.95%). ANIK annual operating expenses is now at all-time high.ANIK Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$26.36 M
-$848.00 K-3.12%
30 September 2024
Summary:
Anika Therapeutics quarterly total operating expenses is currently $26.36 million, with the most recent change of -$848.00 thousand (-3.12%) on 30 September 2024. Over the past year, it has dropped by -$6.26 million (-19.20%). ANIK quarterly operating expenses is now -25.54% below its all-time high of $35.40 million, reached on 31 March 2023.ANIK Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | -19.2% |
| 3 y3 years | +54.0% | +4.7% |
| 5 y5 years | +144.7% | +125.3% |
ANIK Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +54.0% | -25.5% | +4.7% |
| 5 y | 5 years | at high | +149.0% | -25.5% | +125.3% |
| alltime | all time | at high | +5742.6% | -25.5% | >+9999.0% |
Anika Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $26.36 M(-3.1%) |
| June 2024 | - | $27.20 M(-8.4%) |
| Mar 2024 | - | $29.69 M(+6.3%) |
| Dec 2023 | $128.54 M(+13.8%) | $27.92 M(-14.4%) |
| Sept 2023 | - | $32.62 M(+0.0%) |
| June 2023 | - | $32.60 M(-7.9%) |
| Mar 2023 | - | $35.40 M(+14.9%) |
| Dec 2022 | $112.98 M(+11.4%) | $30.80 M(+7.8%) |
| Sept 2022 | - | $28.58 M(+1.2%) |
| June 2022 | - | $28.24 M(+11.4%) |
| Mar 2022 | - | $25.36 M(-4.1%) |
| Dec 2021 | $101.42 M(+21.5%) | $26.43 M(+5.0%) |
| Sept 2021 | - | $25.17 M(-0.4%) |
| June 2021 | - | $25.28 M(+3.0%) |
| Mar 2021 | - | $24.54 M(+7.6%) |
| Dec 2020 | $83.49 M(+61.8%) | $22.81 M(+8.0%) |
| Sept 2020 | - | $21.12 M(+10.7%) |
| June 2020 | - | $19.08 M(-6.8%) |
| Mar 2020 | - | $20.48 M(+25.5%) |
| Dec 2019 | $51.62 M(-1.7%) | $16.32 M(+39.5%) |
| Sept 2019 | - | $11.70 M(+0.3%) |
| June 2019 | - | $11.67 M(-2.2%) |
| Mar 2019 | - | $11.93 M(+17.0%) |
| Dec 2018 | $52.53 M(+30.3%) | $10.19 M(+2.6%) |
| Sept 2018 | - | $9.93 M(-10.9%) |
| June 2018 | - | $11.15 M(-47.5%) |
| Mar 2018 | - | $21.25 M(+94.2%) |
| Dec 2017 | $40.33 M(+40.3%) | $10.94 M(+2.6%) |
| Sept 2017 | - | $10.66 M(+13.2%) |
| June 2017 | - | $9.42 M(+1.3%) |
| Mar 2017 | - | $9.30 M(+10.1%) |
| Dec 2016 | $28.75 M(+20.7%) | $8.45 M(+18.9%) |
| Sept 2016 | - | $7.10 M(+0.8%) |
| June 2016 | - | $7.05 M(+14.6%) |
| Mar 2016 | - | $6.15 M(-18.4%) |
| Dec 2015 | $23.81 M(+2.6%) | $7.54 M(+40.4%) |
| Sept 2015 | - | $5.37 M(+3.3%) |
| June 2015 | - | $5.20 M(-8.8%) |
| Mar 2015 | - | $5.70 M(+0.8%) |
| Dec 2014 | $23.22 M(+16.1%) | $5.66 M(-6.4%) |
| Sept 2014 | - | $6.04 M(+5.3%) |
| June 2014 | - | $5.74 M(-0.7%) |
| Mar 2014 | - | $5.78 M(+30.5%) |
| Dec 2013 | $20.00 M(-0.6%) | $4.43 M(-7.8%) |
| Sept 2013 | - | $4.81 M(-8.1%) |
| June 2013 | - | $5.23 M(-5.4%) |
| Mar 2013 | - | $5.53 M(+10.4%) |
| Dec 2012 | $20.12 M(-16.3%) | $5.01 M(+3.9%) |
| Sept 2012 | - | $4.82 M(-10.9%) |
| June 2012 | - | $5.41 M(+10.7%) |
| Mar 2012 | - | $4.88 M(-23.7%) |
| Dec 2011 | $24.03 M(-0.7%) | $6.40 M(+2.5%) |
| Sept 2011 | - | $6.24 M(+7.5%) |
| June 2011 | - | $5.81 M(+4.1%) |
| Mar 2011 | - | $5.58 M(+0.6%) |
| Dec 2010 | $24.19 M(+29.2%) | $5.54 M(-2.5%) |
| Sept 2010 | - | $5.68 M(-16.5%) |
| June 2010 | - | $6.80 M(+10.4%) |
| Mar 2010 | - | $6.16 M(+89.6%) |
| Dec 2009 | $18.73 M(+2.0%) | $3.25 M(-37.8%) |
| Sept 2009 | - | $5.23 M(+4.0%) |
| June 2009 | - | $5.02 M(-4.0%) |
| Mar 2009 | - | $5.23 M(+6.8%) |
| Dec 2008 | $18.36 M | $4.89 M(+12.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | $4.37 M(-3.5%) |
| June 2008 | - | $4.52 M(-1.1%) |
| Mar 2008 | - | $4.58 M(+6.9%) |
| Dec 2007 | $12.36 M(+20.1%) | $4.28 M(+45.2%) |
| Sept 2007 | - | $2.95 M(+8.7%) |
| June 2007 | - | $2.71 M(+12.0%) |
| Mar 2007 | - | $2.42 M(+23.3%) |
| Dec 2006 | $10.30 M(+1.5%) | $1.96 M(-16.7%) |
| Sept 2006 | - | $2.36 M(-24.1%) |
| June 2006 | - | $3.11 M(+8.4%) |
| Mar 2006 | - | $2.87 M(+22.4%) |
| Dec 2005 | $10.14 M(+0.1%) | $2.34 M(-1.3%) |
| Sept 2005 | - | $2.37 M(-19.2%) |
| June 2005 | - | $2.94 M(+17.8%) |
| Mar 2005 | - | $2.49 M(-15.2%) |
| Dec 2004 | $10.13 M(+48.9%) | $2.94 M(+20.1%) |
| Sept 2004 | - | $2.44 M(-3.4%) |
| June 2004 | - | $2.53 M(+14.3%) |
| Mar 2004 | - | $2.21 M(+15.4%) |
| Dec 2003 | $6.80 M(-18.5%) | $1.92 M(+40.5%) |
| Sept 2003 | - | $1.37 M(-14.2%) |
| June 2003 | - | $1.59 M(-17.2%) |
| Mar 2003 | - | $1.92 M(+4.3%) |
| Dec 2002 | $8.35 M(-20.4%) | $1.84 M(-2.8%) |
| Sept 2002 | - | $1.90 M(-22.1%) |
| June 2002 | - | $2.44 M(+12.4%) |
| Mar 2002 | - | $2.17 M(+3.3%) |
| Dec 2001 | $10.49 M(+40.9%) | $2.10 M(+9.0%) |
| Sept 2001 | - | $1.93 M(-47.5%) |
| June 2001 | - | $3.67 M(+30.9%) |
| Mar 2001 | - | $2.80 M(+279.7%) |
| Dec 2000 | $7.45 M(+3.7%) | $737.70 K(-60.4%) |
| Sept 2000 | - | $1.86 M(-16.4%) |
| June 2000 | - | $2.23 M(-14.4%) |
| Mar 2000 | - | $2.61 M(+102.9%) |
| Dec 1999 | $7.18 M(+30.6%) | $1.28 M(-38.9%) |
| Sept 1999 | - | $2.10 M(+5.0%) |
| June 1999 | - | $2.00 M(+11.1%) |
| Mar 1999 | - | $1.80 M(+20.0%) |
| Dec 1998 | $5.50 M(+25.0%) | $1.50 M(-6.3%) |
| Sept 1998 | - | $1.60 M(+23.1%) |
| June 1998 | - | $1.30 M(+18.2%) |
| Mar 1998 | - | $1.10 M(-21.4%) |
| Dec 1997 | $4.40 M(+37.5%) | $1.40 M(+40.0%) |
| Sept 1997 | - | $1.00 M(0.0%) |
| June 1997 | - | $1.00 M(+25.0%) |
| Mar 1997 | - | $800.00 K(-38.5%) |
| Dec 1996 | $3.20 M(-15.8%) | - |
| Nov 1996 | - | $1.30 M(-7.1%) |
| Aug 1996 | - | $1.40 M(+40.0%) |
| Aug 1996 | $3.80 M(+52.0%) | - |
| May 1996 | - | $1.00 M(0.0%) |
| Feb 1996 | - | $1.00 M(+42.9%) |
| Nov 1995 | - | $700.00 K(+16.7%) |
| Aug 1995 | $2.50 M(+4.2%) | $600.00 K(0.0%) |
| May 1995 | - | $600.00 K(0.0%) |
| Feb 1995 | - | $600.00 K(-14.3%) |
| Nov 1994 | - | $700.00 K(+16.7%) |
| Aug 1994 | $2.40 M(+9.1%) | $600.00 K(-14.3%) |
| May 1994 | - | $700.00 K(+16.7%) |
| Feb 1994 | - | $600.00 K(0.0%) |
| Nov 1993 | - | $600.00 K(-70.0%) |
| Aug 1993 | $2.20 M | $2.00 M(+1900.0%) |
| May 1993 | - | $100.00 K |
FAQ
- What is Anika Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Anika Therapeutics?
- What is Anika Therapeutics annual operating expenses year-on-year change?
- What is Anika Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Anika Therapeutics?
- What is Anika Therapeutics quarterly operating expenses year-on-year change?
What is Anika Therapeutics annual total operating expenses?
The current annual operating expenses of ANIK is $128.54 M
What is the all time high annual operating expenses for Anika Therapeutics?
Anika Therapeutics all-time high annual total operating expenses is $128.54 M
What is Anika Therapeutics annual operating expenses year-on-year change?
Over the past year, ANIK annual total operating expenses has changed by +$15.56 M (+13.77%)
What is Anika Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ANIK is $26.36 M
What is the all time high quarterly operating expenses for Anika Therapeutics?
Anika Therapeutics all-time high quarterly total operating expenses is $35.40 M
What is Anika Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ANIK quarterly total operating expenses has changed by -$6.26 M (-19.20%)